John F. Hamilton
BOARD OF DIRECTORS
pharmaceutical
Aridis Pharmaceuticals
United States of America
Biography
John F. Hamilton, M.B.A. Director Mr. Hamilton was elected to Aridis' Board in 2015. Previously, he served as a director and audit chair of three companies: Vermillion Inc. from 2008 to 2013, Anesiva, Inc. in 2009 and Encompass Funds from 2012 to 2015. From 1997 until his retirement in 2007, Mr. Hamilton served as Vice President and Chief Financial Officer of Depomed, Inc., a specialty pharmaceutical company. Mr. Hamilton began his career in international banking with The Philadelphia National Bank and Crocker National Bank and went on to hold senior financial positions at several biopharmaceutical companies, including Glyko, Inc., which is now BioMarin Pharmaceuticals, and Chiron Corporation, since being acquired by Novartis. He sits on the regional Board of Directors of the Association of Bioscience Financial Officers. Mr. Hamilton received his MBA from the University of Chicago and B.A. from the University of Pennsylvania.
Research Interest
pharmaceutical